Metropolregion München
Kontaktinformationen
1130 Follower:innen
500+ Kontakte
Info
Aktivitäten
-
Reflections on my past two years in biotech It has been now almost two years since I accepted the position of CSO at DISCO Pharmaceuticals. Time to…
Reflections on my past two years in biotech It has been now almost two years since I accepted the position of CSO at DISCO Pharmaceuticals. Time to…
Beliebt bei Carsten Reinhardt
-
I had the privilege to attend the awards ceremony for the @Andreas & Thomas Strüngmann Award 2024. Huge congratulations to this year's winner, Haya…
I had the privilege to attend the awards ceremony for the @Andreas & Thomas Strüngmann Award 2024. Huge congratulations to this year's winner, Haya…
Beliebt bei Carsten Reinhardt
-
Did you know that nearly every five minutes, a person is diagnosed with one of the five gynecological cancers?* Our Director Clinical Development…
Did you know that nearly every five minutes, a person is diagnosed with one of the five gynecological cancers?* Our Director Clinical Development…
Beliebt bei Carsten Reinhardt
Berufserfahrung und Ausbildung
Veröffentlichungen
-
The Development of Herceptin®: Paving the Way for Individualized Cancer Therapy
Modern Biopharmaceuticals
-
Normalization of elevated CD4neg and CD8 neg (double negative) T lymphocytes after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
Annals of Neurology
-
In vivo expansion of HLA-B35 alloreactive T cells sharing homologous T cell receptors
Journal of Experimental Medicine
-
Cytotoxic T Lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self-peptides
Journal of Immunology
Weitere Aktivitäten von Carsten Reinhardt
-
What a day for Bright Peak! We managed to secure a $90M Series C allowing us to advance our lead program, a PD1-targeted IL-18 immunoconjugate…
What a day for Bright Peak! We managed to secure a $90M Series C allowing us to advance our lead program, a PD1-targeted IL-18 immunoconjugate…
Beliebt bei Carsten Reinhardt
-
We’re thrilled to announce the permanent appointment of Dr Mairi Gibbs as our new Chief Executive Officer. Mairi – who was previously interim CEO…
We’re thrilled to announce the permanent appointment of Dr Mairi Gibbs as our new Chief Executive Officer. Mairi – who was previously interim CEO…
Beliebt bei Carsten Reinhardt
-
Love it! That's exactly the point in life that matters!
Love it! That's exactly the point in life that matters!
Beliebt bei Carsten Reinhardt
-
Join me in celebrating our latest FDA accelerated approval for patients living with relapsed or refractory follicular lymphoma, a significant…
Join me in celebrating our latest FDA accelerated approval for patients living with relapsed or refractory follicular lymphoma, a significant…
Beliebt bei Carsten Reinhardt
-
Evox transition and new career phase I wanted to let you all know that I have decided to step down as CEO of Evox Therapeutics and have now passed…
Evox transition and new career phase I wanted to let you all know that I have decided to step down as CEO of Evox Therapeutics and have now passed…
Beliebt bei Carsten Reinhardt
-
Meike Hutt, Principal Scientist at Immatics, was invited to present at the Paul-Martini-Stiftung Workshop in Berlin on April 17th. The workshop was…
Meike Hutt, Principal Scientist at Immatics, was invited to present at the Paul-Martini-Stiftung Workshop in Berlin on April 17th. The workshop was…
Beliebt bei Carsten Reinhardt
Weitere ähnliche Profile
Weitere Mitglieder namens Carsten Reinhardt in Deutschland
-
Carsten Reinhardt
-
Carsten Reinhardt
Junior Technology Engineer bei Atlas Copco IAS GmbH
-
Carsten Reinhardt
--
-
Carsten Reinhardt
Artdirektor bei Shanghai.Berlin
Es gibt auf LinkedIn 11 weitere Personen namens Carsten Reinhardt, die sich in Deutschland befinden.
Weitere Mitglieder anzeigen, die Carsten Reinhardt heißen